06/15/2026
Promising new clinical trials at the Hadassah Medical Organization are offering fresh hope in the fight against pancreatic cancer.
Dr. Philip Blumenfeld, director of Hadassah's Advanced Radiotherapy Unit, shared his findings with the Cancer Network, including 100% local disease control in two pancreatic cancer trials using Alpha DaRT. This innovative treatment delivers radiation directly into tumors while minimizing exposure to surrounding healthy tissue.
Among the patients evaluated, tumors either shrank or stopped growing at the treated site, and no serious treatment-related side effects were reported.
"As a radiation oncologist and member of a multidisciplinary pancreatic cancer team, I see these results as potentially addressing a significant unmet need from several clinical perspectives," said Dr. Blumenfeld.
With pancreatic cancer remaining one of the most challenging cancers to treat, advances like these underscore the power of groundbreaking research and the lifechanging impact of medical innovation.
👉 Click to read more about his interview with the Cancer Network: https://www.hadassah.org/story/new-pancreatic-cancer-trials-show-100-local-disease-control
Two pancreatic cancer clinical trials at the Hadassah Medical Organization in Israel using Alpha DaRT show promising results
